Blood marker may predict deadly bleeding in Life-Support patients

NCT ID NCT07039513

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether changes in a blood marker called D-dimer can warn doctors about serious bleeding in patients on ECMO, a life-support machine for heart or lung failure. Researchers will track 100 intensive care patients and measure D-dimer levels over time. The goal is to find a threshold that signals high bleeding risk within the next 24 hours, which could help prevent complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors predict and prevent life-threatening bleeding in ECMO patients, making the treatment safer.

What could go wrong

This is an observational study, not a treatment trial. It may not find a clear threshold, and results may not apply to all ECMO patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ECMO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service de Médecine Intensive - Réanimation Nouvel Hôpital Civil

    Strasbourg, 67098, France